Purchases and Sales Made in Q4 2022 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q4 2022. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-203K- 24.66% |
$2.01M - $2.97M
|
622K
$12.2M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-203K- 24.66% |
$2.01M - $2.97M
|
622K
$12.2M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-353K- 9.78% |
$3.48M - $5.14M
|
3.25M
$63.7M
|
|
|
Feb 14, 2023
Q4 2022
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-560K- 56.45% |
$5.52M - $8.17M
|
432K
$8.46M
|